Bioequivalence and Bioavailability Forum

Dears,

In a in a bioequivalence study with a full replicate design conducted in more than one group, how shall the group participants be separated/divided?

For example,

Initially we have 3 groups but because of some constraints the washouts for a few participants had to be extended.

The participants will be added to the groups accordingly with the administration date of the first period (even if the other periods can have a different administration date) or the groups shall be formed accordingly with the date of administration of all the periods (for each group all the administration date of the 4 periods has to be the same)?


I hope I was clear.

Thank you for the help.

---

Edit: Category changed; see also this post #1. [Helmut]